1. Home
  2. ACXP vs GIPR Comparison

ACXP vs GIPR Comparison

Compare ACXP & GIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • GIPR
  • Stock Information
  • Founded
  • ACXP 2017
  • GIPR 2015
  • Country
  • ACXP United States
  • GIPR United States
  • Employees
  • ACXP N/A
  • GIPR N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • GIPR Real Estate Investment Trusts
  • Sector
  • ACXP Health Care
  • GIPR Real Estate
  • Exchange
  • ACXP Nasdaq
  • GIPR Nasdaq
  • Market Cap
  • ACXP 6.8M
  • GIPR 6.4M
  • IPO Year
  • ACXP 2021
  • GIPR 2021
  • Fundamental
  • Price
  • ACXP $4.45
  • GIPR $1.02
  • Analyst Decision
  • ACXP Strong Buy
  • GIPR
  • Analyst Count
  • ACXP 3
  • GIPR 0
  • Target Price
  • ACXP $143.67
  • GIPR N/A
  • AVG Volume (30 Days)
  • ACXP 75.7K
  • GIPR 69.6K
  • Earning Date
  • ACXP 11-12-2025
  • GIPR 11-17-2025
  • Dividend Yield
  • ACXP N/A
  • GIPR N/A
  • EPS Growth
  • ACXP N/A
  • GIPR N/A
  • EPS
  • ACXP N/A
  • GIPR N/A
  • Revenue
  • ACXP N/A
  • GIPR $9,953,920.00
  • Revenue This Year
  • ACXP N/A
  • GIPR $1.12
  • Revenue Next Year
  • ACXP N/A
  • GIPR $0.52
  • P/E Ratio
  • ACXP N/A
  • GIPR N/A
  • Revenue Growth
  • ACXP N/A
  • GIPR N/A
  • 52 Week Low
  • ACXP $3.80
  • GIPR $0.78
  • 52 Week High
  • ACXP $29.40
  • GIPR $2.06
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 41.55
  • GIPR 44.01
  • Support Level
  • ACXP $4.51
  • GIPR $0.91
  • Resistance Level
  • ACXP $5.79
  • GIPR $1.13
  • Average True Range (ATR)
  • ACXP 0.44
  • GIPR 0.09
  • MACD
  • ACXP -0.09
  • GIPR -0.01
  • Stochastic Oscillator
  • ACXP 24.34
  • GIPR 38.71

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About GIPR Generation Income Properties Inc.

Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.

Share on Social Networks: